Seeking Alpha

Johnson & Johnson (JNJ +0.3%) subsidiary Janssen Pharmaceutical days the FDA has approved a...

Johnson & Johnson (JNJ +0.3%) subsidiary Janssen Pharmaceutical days the FDA has approved a broader indication for Zytiga. The drug, in combination with prednisone, may now be used earlier in the treatment continuum, before the use of chemotherapy. Zytiga also received a positive opinion for an expanded indication from the EMA and is under review by other health authorities worldwide.
Comments (1)
  • It seems that slowly, but surely, the news flow re: JNJ is turning positive.
    10 Dec 2012, 04:39 PM Reply Like
DJIA (DIA) S&P 500 (SPY)